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The treatment of quetiapine and/or citalopram poisoning is mainly supportive and involves gastric lavage, activated 
charcoal, intubation, and mechanical ventilation. Recently, however, there were reports of successful treatment with 
intravenous lipid emulsion. Here we report a case of a 19-year-old Caucasian girl who ingested approximately 6000 mg 
of quetiapine, 400 mg of citalopram, and 45 mg of bromazepam in a suicide attempt. The patient developed ventricular 
tachycardia and epileptic seizures 12 h after admission to the hospital. As the patient’s condition deteriorated, we combined 
standard therapy (intubation, mechanical ventilation, and vasopressors) with low-dose intravenous lipid emulsion (ILE) 
(a total of 300 mL of 20 % lipid emulsion) and normalised her heart rhythm and stopped the seizures. She was discharged 
to the psychiatric ward after 48 h and home after a prolonged (2-month) psychiatric rehabilitation. Intravenous lipid 
emulsion turned out to be effective even in the lower dose range than previously reported for quetiapine poisoning in 
patients presenting with seizure and ventricular arrhythmia. To our knowledge, there are no case reports describing the 
use of ILE in treating citalopram poisoning.
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Severe poisoning with quetiapine or citalopram can lead 
to life-threatening dysrhythmias and epileptic seizures. 
Therapy is mainly supportive (1-2). In recent years, there 
have been reports of successful use of intravenous lipid 
emulsions (ILE) to counter poisoning with lipophilic drugs, 
mainly local anaesthetics, beta blockers, and calcium 
channel blockers (3), including quetiapine (4-6). Here we 
present a patient with severe poisoning with quetiapine and 
citalopram (yet another lipophilic substance), who was 
successfully treated with ILE in the lower dose range than 
reported in most cases.
CASE REPORT
A 19-year-old girl was admitted to the hospital after 
having ingested about 6000 mg of quetiapine (20 300-mg 
tablets), 400 mg of citalopram, and 45 mg of bromazepam 
in a suicide attempt. The doses of ingested drugs were 
determined from medical history and empty packaging. On 
admission the patient was aroused; her Glasgow coma scale 
was 11, blood pressure 128/60 mmHg (17.1/8 kPa), and 
peripheral oxygen saturation without supplemental oxygen 
was 95 %. The pupils were dilated, symmetrical, and poorly 
reactive to light. Electrocardiogram revealed sinus 
tachycardia with the heart rate of 150 min-1, incomplete 
right bundle branch block, and prolonged corrected QT 
interval of 510 ms. We performed gastric lavage, applied 
activated charcoal, and drew urine for toxicology testing, 
which turned positive for quetiapine and citalopram. The 
concentrations of quetiapine and citalopram were not 
determined.
Twelve hours after the admission, we registered 
monomorphic premature ventricular contractions (PVCs) 
and generalised epileptic seizures. During the hour that 
followed, PVCs became more frequent and progressed to 
ventricular tachycardia with pulse, whereas epileptic 
seizures progressed to generalised convulsive status 
epilepticus, which was unresponsive to multiple bolus doses 
of diazepam. Potassium was just below the normal range, 
and magnesium was normal (3.71 mmol L-1, and 
0.78 mmol L-1, respectively). She was intubated and 
ventilated mechanically. The maximum prolongation of 
corrected QT interval was 570 ms. Because of the 
combination of life-threatening arrhythmia and epileptic 
seizures we decided to infuse 100 mL of 20 % lipids 
(1.5 mL kg-1 of Lipofundin MCT/LCT 20 %, B. Braun 
Melsungen AG, Melsungen, Germany, composed of soya 
oil 100 g per 1000 mL of emulsion, medium-chain 
triglycerides 100 g per 1000 mL of emulsion, glycerol, 
egg-lecithin, α-tocopherol, and sodium oleate) over 10 min, 
followed by additional 200 mL over the following 2 h. As 
soon as the first 100 mL were infused, the corrected QT 
interval dropped to normal (370 ms), and ventricular 
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tachycardia and epileptic seizures stopped entirely. 
Subsequent treatment in the ICU was uneventful. The 
patient was extubated 24 h later, and her level of 
consciousness returned to normal (Glasgow coma scale 15). 
She was transferred to the psychiatric ward on the following 
day and was discharged home after two months of 
psychiatric rehabilitation.
DISCUSSION
Quetiapine is an atypical antipsychotic used for the 
treatment of schizophrenia, bipolar disorders, depression, 
and sleeping disturbances. Its antipsychotic effects are 
mediated via serotonin 5HT2 and dopamine D1 and D2 
receptors. It also has affinity for serotonin 5HT1A, 
muscarinic M1, adrenergic α-1 and α-2, and histamine H1 
receptors. An overdose results in hypotension, sinus 
tachycardia, cardiac dysrhythmias, prolongation of the 
corrected QT interval, delirium, seizures, central nervous 
system depression, respiratory depression, coma, and death 
(1, 5, 7).
Citalopram is a selective serotonin reuptake inhibitor 
(SSRI). In overdosed patients it has shown higher toxicity 
than other SSRIs, manifesting in the prolongation of 
corrected QT interval, widening of the QRS complexes, 
tachycardia, generalised convulsions, acute respiratory 
distress syndrome, rhabdomyolysis with acute renal failure, 
and CNS depression (2, 8). To our knowledge, there are no 
case reports describing the use of ILE in treating citalopram 
poisoning.
ILE is a treatment strategy for lipophilic drug 
poisonings. At least two explanations exist regarding the 
mechanism of action: firstly, the lipid sink theory proposes 
a separate pharmacologic compartment into which the 
lipophilic drug may diffuse from the tissues, and secondly, 
the delivery of energy-rich substrate to energy depleted 
cells (e.g. myocardium) might improve their function. The 
lipid sink theory is the most widely accepted mechanism 
of action. A number of commercial products with different 
lipid formulations have been successfully used to treat 
lipophilic drug poisonings. However, not all effects of ILE 
can be explained solely by the lipid sink theory, especially 
rapid effects immediately after the start of the infusion (3, 
4).
The decision to use ILE in our patient was based on the 
occurrence of sustained ventricular tachycardia and 
generalised epileptic seizures. Standard treatment (gastric 
lavage, activated charcoal, intubation, mechanical 
ventilation) did not succeed in preventing life-threatening 
complications. Immediately after the infusion of ILE our 
patient’s condition improved, and we observed no 
complications attributable to ILE. Successful use of ILE in 
quetiapine poisoning has been described before. Finn et al. 
(6) described a patient who attempted suicide by ingestion 
of 4300 mg of quetiapine and 3100 mg of sertraline. The 
patient presented with hypotension and hypothermia but 
had no epileptic seizures or arrhythmias. The patient 
received symptomatic treatment and infusion of 20 % ILE. 
Like in our case, the initial bolus dose was 1.5 mL kg-1 
(100 mL), followed by an infusion of 6 mL kg-1 h-1 for 1 h 
(in total 400 mL). His level of consciousness improved soon 
after the administration of ILE, which removed the need 
for intubation and mechanical ventilation. Eren Cevik et al. 
(9) reported on a patient who ingested 2400 mg of 
quetiapine. That patient presented with hypotension and 
sinus tachycardia. The patient received ILE consisting of 
100 mL bolus, followed by 30 mL kg-1 h-1infusion over 2 h 
(total dose of 3580 mL). Bartos and Knudsen (5) presented 
a female patient who ingested 24000 mg of quetiapine. Her 
cardiovascular collapse was refractory to all standard 
symptomatic treatment (intubation, mechanical ventilation, 
vasopressors). She was treated with 20 % ILE 170 mL bolus, 
followed by an infusion of 500 mL over 1 h. In all these 
cases treatment with ILE was reported efficient.
We used a similar initial bolus compared to other 
authors, but due to a clear clinical improvement, we 
continued the treatment at lower doses (cumulatively 
300 mL). The treatment showed no adverse effects such as 
allergic reactions, fat overload syndrome with 
hepatosplenomegaly, jaundice, acute pancreatitis, seizures, 
fat embolism, coagulopathies or alteration of laboratory 
tests (10-11).
To conclude, treatment with ILE for severe poisoning 
with quetiapine and citalopram could be effective even in 
the lower dose range than previously reported.
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Zdravljenje hude zastrupitve s kvetiapinom in citalopramom z nizkim odmerkom intravenske lipidne emulzije
Zastrupitve s kvetiapinom in/ali citalopramom večinoma zdravimo podporno. Ob zdravljenju s spiranjem želodca, aktivnim 
ogljem, intubacijo in mehansko ventilacijo pa so opisani primeri uspešnega zdravljenja z intravensko lipidno emulzijo. 
Predstavljamo primer 19-letne ženske, ki je v samomorilne namene zaužila približno 6000 mg kvetiapina, 400 mg 
citaloprama in 45 mg bromazepama. Bolnica je imela 12 ur po sprejemu prekatno tahikardijo in epileptične napade. Ob 
kliničnem poslabšanju stanja smo jo zdravili s standardno terapijo (intubacija, mehanska ventilacija, vazopresorna podpora) 
in nizkim odmerkom intravenske lipidne emulzije (celokupno 300 mL 20 % lipidne emulzije). Srčni ritem se je po terapiji 
normaliziral, epileptični krči so prenehali. Po 48 urah zdravljenja v enoti intenzivne terapije je bila premeščena na oddelek 
za psihiatrijo in po 2-mesečnem zdravljenju domov. Zastrupitev s kvetiapinom in citalopramom, ki se pri bolniku kaže z 
epileptičnimi krči in prekatnimi motnjami ritma, lahko uspešno zdravimo z nizkimi odmerki intravenske lipidne emulzije.
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